Recent Finacing
Recent Raise
Calimmune is a clinical-stage biotech developing Cal-1, a gene therapy to control HIV by reducing CCR5 and blocking viral fusion through autologous stem- and T-cell infusions in Phase I/II trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
